Cita APA (7a ed.)
Tebben, P. J., Alexander, T., Mora, S., Padidela, R., Roberts, M. S., Li, D., . . . Gafni, R. I. (Oct-Nov 2025). SUN-777 CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant Hypocalcemia Type1. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaf149.725
Cita Chicago Style (17a ed.)
Tebben, Peter J., Todd Alexander, Stefano Mora, Raja Padidela, Mary Scott Roberts, Dingfeng Li, Scott Adler, y Rachel I. Gafni. "SUN-777 CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant Hypocalcemia Type1." Journal of the Endocrine Society Oct-Nov 2025. https://doi.org/10.1210/jendso/bvaf149.725.
Cita MLA (9a ed.)
Tebben, Peter J., et al. "SUN-777 CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant Hypocalcemia Type1." Journal of the Endocrine Society, Oct-Nov 2025, https://doi.org/10.1210/jendso/bvaf149.725.
Precaución: Estas citas no son 100% exactas.